scholarly journals Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine

2009 ◽  
Vol 58 (9) ◽  
pp. 1397-1405 ◽  
Author(s):  
Govind Ragupathi ◽  
Payal Damani ◽  
Geeta Srivastava ◽  
Om Srivastava ◽  
Steven J. Sucheck ◽  
...  
Keyword(s):  
Cancer ◽  
1995 ◽  
Vol 75 (8) ◽  
pp. 2051-2056 ◽  
Author(s):  
Takamori Nakayama ◽  
Masahiko Watanabe ◽  
Takao Katsumata ◽  
Tatsuo Teramoto ◽  
Masaki Kitajima

2021 ◽  
Vol 9 ◽  
Author(s):  
Deepak Ganesh ◽  
Prashant Jain ◽  
Chethan Devanur Shanthamurthy ◽  
Suraj Toraskar ◽  
Raghavendra Kikkeri

Selectins are type-I transmembrane glycoproteins that are ubiquitously expressed on activated platelets, endothelial cells, and leukocytes. They bind to cell surface glycoproteins and extracellular matrix ligands, regulate the rolling of leukocytes in the blood capillaries, and recruit them to inflammatory sites. Hence, they are potential markers for the early detection and inhibition of inflammatory diseases, thrombosis, cardiovascular disorders, and tumor metastasis. Fucosylated and sialylated glycans, such as sialyl Lewisx, its isoform sialyl Lewisa, and heparan sulfate, are primary selectin ligands. Functionalization of these selectin-binding ligands on multivalent probes, such as nanoparticles, liposomes, and polymers, not only inhibits selectin-mediated biological activity but is also involved in direct imaging of the inflammation site. This review briefly summarizes the selectin-mediated various diseases such as thrombosis, cancer and recent progress in the different types of multivalent probes used to target selectins.


Author(s):  
Takashi Kishimoto ◽  
Hiroshi Ishikura ◽  
Chisa Kimura ◽  
Toshiyuki Takahashi ◽  
Hiroyuki Kato ◽  
...  

Cancer ◽  
1997 ◽  
Vol 79 (9) ◽  
pp. 1686-1697 ◽  
Author(s):  
Mepur H. Ravindranath ◽  
Amir A. Amiri ◽  
Philip M. Bauer ◽  
Mark C. Kelley ◽  
Richard Essner ◽  
...  

2000 ◽  
Vol 78 (6) ◽  
pp. 892-904 ◽  
Author(s):  
Beat Ernst ◽  
Bea Wagner ◽  
Gabi Baisch ◽  
Andreas Katopodis ◽  
Tammo Winkler ◽  
...  

Fucosyl transferase III (FucT III) has previously been characterized as the most general enzyme of the FucT family, as judged from its ability to catalyze the transfer of fucose to both Galβ(1-3)GlcNAc and Galβ(1-4)GlcNAc. In order to explore the synthetic potential of FucT III for the enzymatic synthesis of sialyl Lewisx and sialyl Lewisa derivatives, its substrate specificity has been probed using a number of natural substrate mimetics. A remarkable range of acceptor substrates was found when N-acetyl glucosamine was replaced by D-glucal, (R,R)-1,2-cyclohexanediol and (R,R)-butan-2,3-diol. Although the reaction rates were low compared to the reaction with the natural substrates, they proved to be sufficient for the synthesis of preparative amounts.Key words: fucosyl transferase III, sialyl Lewisa, sialyl Lewisx, carbohydrate mimetics.


1993 ◽  
Vol 54 (2) ◽  
pp. 91-97 ◽  
Author(s):  
Tsukasa Takabayashi ◽  
Masahiko Watanabe ◽  
Yoichi Sakurai ◽  
Kokichi Sugano ◽  
Susumu Kodaira ◽  
...  

2013 ◽  
Vol 60 (2) ◽  
Author(s):  
Małgorzata Borzym-Kluczyk ◽  
Iwona Radziejewska

Sialic acid and sialyl Lewisa/x are found on N- and O-glycans of many human malignant cells. Carbohydrate antigens can be used as tumor markers, and an increase of their levels in cancer cells is associated with tumor progression. The aim of this study was to assess the level of some Lewis blood group antigens on glycoproteins in tumor (cancer tissue), intermediate zone (adjacent to tumor tissue), and normal renal cortex/medulla (uninvolved by tumor). The study was performed on tissues taken from 30 patients. Relative amounts of sugar structures of proteins with molecular masses above 30 kDa were determined by ELISA-like test with biotinylated lectins: MAA (Maackia amurensis), SNA (Sambucus nigra), and monoclonal antibodies anti-sialyl Lewisa/x.∙ Higher expression of all examined structures was revealed in cancer tissues. Significant increases were observed for sialic acid linked α 2-3 in cancer tissues when compared to healthy ones and also among intermediate and healthy tissues. The sialic acid linked α 2-6 and sialyl Lewisx structures were significantly increased in cancerous cells when compared to normal and intermediate renal tissue. In case of sialyl Lewisa antigen, a significant difference was discovered between normal and intermediate tissue. Our results confirm that the examined Lewis antigens can be involved in tumor development. Their increase in cancer tissues can suggest their specific role in the process.


2011 ◽  
Vol 17 (5) ◽  
pp. 1024-1032 ◽  
Author(s):  
Ritsuko Sawada ◽  
Shu-Man Sun ◽  
Xiaohong Wu ◽  
Feng Hong ◽  
Govind Ragupathi ◽  
...  

2002 ◽  
Vol 40 (5) ◽  
pp. 440-449 ◽  
Author(s):  
S E Baldus ◽  
S P Monig ◽  
F-G Hanisch ◽  
T K Zirbes ◽  
U Flucke ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document